ກົນໄກເຄື່ອງສະແດງສາມລະດັບ ແລະ ເຄື່ອງຄອມພິວເຕີໃຊ້ຄືກັນ
关于老挝专利「ກົນໄກເຄື່ອງສະແດງສາມລະດັບ ແລະ ເຄື່ອງຄອມພິວເຕີໃຊ້ຄືກັນ」，老商通整理了如下公开信息，由 LEE, Eun Suk 于 2010-09-17 提交申请，当前状态为等待形式审查。标识字段包括：申请号 P/184；DIP 编号 LAP184；主管局代码 LA；保护类型 Patent - PCT National Phase。时间线要点：公开/公告日 2025-11-14。国际分类 / IPC 标注为 G06F 13/10、G06F 3/14。发明人 / 设计人包括 LEE, Eun Suk。代理机构 / 代理人记载为 LAO INTERCONSULT CO., LTD.。公开摘要提示：The invention in the sphere of pharmaceuticals and medicine is a pharmaceutical composition。
The following summary describes a Laos patent titled “TRIPLE DISPLAY DEVICE, AND COMPUTER EMPLOYING SAME”, filed by LEE, Eun Suk on 2010-09-17; current status: Awaiting formal examination. Identifiers include application No. P/184; DIP id LAP184; protection kind Patent - PCT National Phase. Key dates: publication 2025-11-14. Classification: G06F 13/10、G06F 3/14. Inventor(s)/designer(s): LEE, Eun Suk. Abstract hint: The invention in the sphere of pharmaceuticals and medicine is a pharmaceutical composition. Unique application identifiers, holders and classification text are surfaced here to reduce near-duplicate IP landing pages; always verify against the competent office.
ໜ້ານີ້ສະຫຼຸບ ສິດທິບັດ «ກົນໄກເຄື່ອງສະແດງສາມລະດັບ ແລະ ເຄື່ອງຄອມພິວເຕີໃຊ້ຄືກັນ» ຈາກຂໍ້ມູນຈົດທະບຽນເປີດ, ຍື່ນໂດຍ LEE, Eun Suk ໃນວັນທີ 2010-09-17; ສະຖານະ ລໍຖ້າກວດຮູບແບບ. ຕົວລະບຸ: ເລກທີຄຳຮ້ອງ P/184; ລະຫັດ DIP LAP184; ປະເພດການປົກປ້ອງ Patent - PCT National Phase. ວັນທີສຳຄັນ: ວັນເຜີຍແຜ່ 2025-11-14. ປະເພດ/ຫ້ອງ: G06F 13/10、G06F 3/14. ນັກປະດິດ/ນັກອອກແບບ: LEE, Eun Suk. ສະຫຼຸບ: The invention in the sphere of pharmaceuticals and medicine is a pharmaceutical composition. ຂໍ້ຄວາມນີ້ເນັ້ນຕົວເລກ, ວັນທີ, ປະເພດ ແລະ ຜູ້ຍື່ນ ເພື່ອຫຼຸດຄວາມຄ້າຍຄືນລະຫວ່າງໜ້າ IP; ກວດຂໍ້ມູນທາງການກ່ອນຕັດສິນໃຈ.
P/184
图样
基础信息
- 类型
- 专利
- 申请号
P/184- 状态
- 等待形式审查
- 申请人
- LEE, Eun Suk
- 代理机构
- LAO INTERCONSULT CO., LTD.
- 申请日期
- 2010-09-17
- 公开/公告日
- 2025-11-14
- 国际分类
- G06F 13/10 · G06F 3/14
- 商品 / 服务
- —
办理流程
根据当前状态动态标注-
提交申请
-
形式审查 进行中
-
实质审查
-
公开
-
授权
关联分析
LaoBiz 企业数据库联动类似专利推荐
摘要
The invention in the sphere of pharmaceuticals and medicine is a pharmaceutical composition
stimulating biosynthesis of S-adenosylmethionine and a peroral drug in tablet dosage form which
has a hepatoprotective effect and can be used for treatment of diseases accompanied by liver injury.
The objective of this invention is to develop a stable peroral drug in tablet dosage form based on a
new non-toxic pharmaceutical composition with the hepatoprotective effect due to stimulation of
biosynthesis of S-adenosylmethionine in hepatic cells.
This objective is achieved by development of a pharmaceutical composition stimulating
biosynthesis of S-adenosylmethionine, a combination of methionine, succinic acid, inosine and
taurin in effective quantities and a peroral drug in tablet dosage form with the hepatoprotective
effect.
The new drug developed on the basis of the pharmaceutical composition stimulating biosynthesis of
S-adenosylmethionine is highly effective and safe, has stable pharmaceutical dosage form and may
be used in long-term therapy of different diseases
The invention in the sphere of pharmaceuticals and medicine is a pharmaceutical composition
stimulating biosynthesis of S-adenosylmethionine and a peroral drug in tablet dosage form which
has a hepatoprotective effect and can be used for treatment of diseases accompanied by liver injury.
The objective of this invention is to develop a stable peroral drug in tablet dosage form based on a
new non-toxic pharmaceutical composition with the hepatoprotective effect due to stimulation of
biosynthesis of S-adenosylmethionine in hepatic cells.
This objective is achieved by development of a pharmaceutical composition stimulating
biosynthesis of S-adenosylmethionine, a combination of methionine, succinic acid, inosine and
taurin in effective quantities and a peroral drug in tablet dosage form with the hepatoprotective
effect.
The new drug developed on the basis of the pharmaceutical composition stimulating biosynthesis of
S-adenosylmethionine is highly effective and safe, has stable pharmaceutical dosage form and may
be used in long-term therapy of different diseases